enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Doctors urged to ditch blue inhalers for asthma treatment ...

   www.aol.com/news/doctors-urged-ditch-blue...

   The new guidelines for doctors recommend against prescribing short-acting, blue reliever inhalers without the corticosteroids contained in preventative medication, saying patients should instead ...

3. Olodaterol - Wikipedia

   en.wikipedia.org/wiki/Olodaterol

   Olodaterol is a once-daily maintenance bronchodilator treatment of airflow obstruction in people with COPD. [3] While it appears to reduce COPD exacerbations it does not appear to alter the speed at which a person's lungs worsen or alter their life expectancy. [3] As of December 2013, olodaterol is not approved as a treatment of asthma.

4. Cromoglicic acid - Wikipedia

   en.wikipedia.org/wiki/Cromoglicic_acid

   as a nasal spray (Rynacrom (UK), Lomusol (France), Nasalcrom (the only over-the-counter form, US), Prevalin (non-direct version, NL)) to treat allergic rhinitis. in a nebulizer solution for aerosol administration to treat asthma. as an inhaler (Intal, Fisons Pharmaceuticals, UK) for preventive management of asthma. [3]

5. Aclidinium bromide - Wikipedia

   en.wikipedia.org/wiki/Aclidinium_bromide

   Aclidinium bromide is a long-acting, inhaled muscarinic antagonist (LAMA) approved in the United States in July 2012 [3] as a maintenance treatment for chronic obstructive pulmonary disease (COPD). [4] Evidence shows that it can improve quality of life and prevent hospitalization in those with COPD. [5]

6. Boehringer to cut out-of-pocket costs for inhalers to $35 - AOL

   www.aol.com/news/boehringer-cut-pocket-costs...

   (Reuters) - Boehringer Ingelheim will reduce out-of-pocket costs for the company's inhaler products for a chronic lung disease and asthma to $35 per month starting June 1, the German drugmaker ...

7. GSK to cap out-of-pocket inhaler costs in US - AOL

   www.aol.com/news/gsk-cap-pocket-inhaler-costs...

   The cost cap would apply to all of its asthma and chronic obstructive pulmonary disease (COPD) medicines, including Advair Diskus, Advair HFA, and Trelegy Ellipta, and would apply to patients ...